| LAZARD EMERGING MARKETS EQUITY S ACC USD | RVI EMERGENTES | 46,63% | 100,16% | 104,12% | · |
| BNP PARIBAS ASIA EX-JAPAN EQUITY PRIVILEGE CAP | RVI ASIA EX-JAPÓN | 46,62% | 86,42% | 49,08% | 121,46% |
| TEMPLETON ASIAN GROWTH A (ACC) SGD-H1 | RVI ASIA EX-JAPÓN CRECIMIENTO | 46,62% | 78,34% | 37,75% | 92,27% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 46,61% | 28,98% | -21,26% | · |
| KUTXABANK BOLSA JAPON, FI ESTANDAR | RVI JAPÓN | 46,60% | 82,28% | 92,51% | 203,24% |
| T.ROWE EMERGING MARKETS EQUITY FUND E (GBP) | RVI EMERGENTES | 46,60% | · | · | · |
| DWS ESG BIOTECH FC | RVI BIOTECNOLOGÍA | 46,58% | 53,09% | 37,20% | · |
| JPM EMERGING MARKETS EQUITY A (ACC) USD | RVI EMERGENTES | 46,55% | 72,57% | 28,97% | 133,73% |
| UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (EUR) N-ACC | RVI EMERGENTES | 46,55% | 82,38% | 30,46% | 121,84% |
| CAPITAL GROUP ASIAN HORIZON FUND (LUX) Z EUR | RVI ASIA EX-JAPÓN | 46,54% | 78,25% | 33,59% | · |
